NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/05/2026
Back to search
Official data from USPTO
N
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
05/05/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
08/12/2025
Registration date
05/05/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2026
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
03
Owner location
Swiftwater, PA, US
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a stylized “N” design. The stylized “N” features a color gradient which changes from orange to green from left to right. The color white in the mark appears only as background and is not claimed.
Holders and representatives
Holders
Sanofi Pasteur Inc.
Representatives
Alexandra Kochian Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; Antibodies for medical purposes; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; Vaccines for human use
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/17/2026
PUBO
PUBLISHED FOR OPPOSITION
03/17/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/20/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/05/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2026
ALIE
ASSIGNED TO LIE
02/05/2026
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/29/2026
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/03/2026
GNSL
LETTER OF SUSPENSION E-MAILED
01/03/2026
CNSL
SUSPENSION LETTER WRITTEN
01/03/2026
DOCK
ASSIGNED TO EXAMINER
12/27/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/23/2025
MAFR
APPLICATION FILING RECEIPT MAILED
08/12/2025
NWAP
NEW APPLICATION ENTERED
08/12/2025
Continuous trademark protection
Get notified about every new filing that threatens N or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.